Table 2 |
||||
|
Clinical manifestations of patients with Behçhet's disease in relation to anti-Sip1 C-ter autoantibodies |
||||
|
Clinical manifestation of the 56 patients with Behçet's disease |
Number of total samples (%) |
Anti-Sip1 C-ter antibody response, number of positive samples (%) |
||
|
|
||||
|
IgG |
IgM |
IgA |
||
|
|
||||
|
Skin lesions |
36 (64) |
7 (19) |
14 (39) |
7 (19) |
|
Ocular inflammation |
38 (68) |
8 (21) |
16 (42) |
5 (13) |
|
Genital aphtosis |
27 (48) |
5 (18) |
8 (29) |
5 (18) |
|
Arthritis |
10 (18) |
1 (10) |
6 (60) |
2 (20) |
|
Vascular manifestations |
10 (18) |
4 (40) |
6 (60) |
4 (40) |
|
Neurological manifestations |
6 (11) |
0 |
1 (1.6) |
0 |
|
|
||||
|
Sip1 C-ter, carboxy-terminal subunit of Sip1. |
||||
|
Delunardo et al. Arthritis Research & Therapy 2006 8:R71 doi:10.1186/ar1940 |
||||
